Correspondence 0001213900-24-107954 from Onconetix, Inc. (ONCO)

Onconetix, Inc.
Date: Dec. 11, 2024 · CIK: 0001782107 · Accession: 0001213900-24-107954

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-282958

Date

December 11, 2024

Author

/s/ Karina M. Fedasz

Form

CORRESP

Company

Onconetix, Inc.

Letter

ONCONETIX, INC.

201 E. Fifth Street, Suite 1900

Cincinnati, OH

December 11, 2024

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, DC 20549

Re: Onconetix, Inc.

Registration Statement on Form S-1

File No. 333-282958

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Onconetix, Inc. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 5:00 p.m. EST on Thursday, December 12, 2024, or as soon as practicable thereafter.

Very truly yours,
/s/ Karina M. Fedasz

Show Raw Text

CORRESP
1
filename1.htm

ONCONETIX, INC.

201 E. Fifth Street, Suite 1900

Cincinnati, OH

December 11, 2024

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

100 F Street, N.E.

Washington, DC 20549

    Re:
    Onconetix, Inc.

    Registration Statement on Form S-1

    File No. 333-282958

Ladies and
Gentlemen:

Pursuant to Rule 461 under
the Securities Act of 1933, as amended, Onconetix, Inc. hereby requests acceleration of effectiveness of the above referenced Registration
Statement so that it will become effective at 5:00 p.m. EST on Thursday, December 12, 2024, or as soon as practicable thereafter.

    Very truly yours,

    /s/ Karina M. Fedasz

    Karina M. Fedasz

    Interim Chief Financial Officer

cc:   Ellenoff Grossman & Schole LLP

SecProbe.io